|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61P 37/00 | (2006.01) |
| (11) | Number of the document | 3551664 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17835592.1 |
| Date of filing the European patent application | 2017-12-07 | |
| (97) | Date of publication of the European application | 2019-10-16 |
| (45) | Date of publication and mention of the grant of the patent | 2021-02-17 |
| (46) | Date of publication of the claims translation | 2021-05-25 |
| (86) | Number | PCT/EP2017/081911 |
| Date | 2017-12-07 |
| (87) | Number | WO 2018/104483 |
| Date | 2018-06-14 |
| (30) | Number | Date | Country code |
| 16306655 | 2016-12-09 | EP |
| (72) |
POIRIER, Nicolas, FR
MARY, Caroline, FR
VANHOVE, Bernard, FR
THEPENIER, Virginie, FR
|
| (73) |
OSE Immunotherapeutics,
22 Boulevard Benoni Goullin, 44200 Nantes,
FR
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Antikūnai ir polipeptidai, nukreipti prieš CD127 |
| ANTIBODIES AND POLYPEPTIDES DIRECTED AGAINST CD127 |
| Payment date | Validity (years) | Amount | |
| 2024-12-06 | 8 | 185.00 EUR |
| 2025-12-07 |